High-dose therapy with autologous haemopoietic stem cell support for Waldenstrom's macroglobulinaemia

British Journal of Haematology

Volumn 105, Issue 4, 1999, Pages 993-996

  Desikan, R ^a,b,c   Dhodapkar, M ^a,b   Siegel, D ^a,b   Fassas, A ^a,b   Singh, J ^a,b   Singhal, S ^a,b   Mehta, J ^a,b   Vesole, D ^a,b   Tricot, G ^a,b   Jagannath, S ^a,b   Anaissie, E ^a,b   Barlogie, B ^a,b   Munshi, N C ^a,b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Autotransplants; Waldenstrom's macroglobulinaemia

Indexed keywords

ALPHA INTERFERON; CHLORAMBUCIL; CLADRIBINE; CYCLOPHOSPHAMIDE; DEXAMETHASONE; ETOPOSIDE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN M; MELPHALAN; PREDNISONE; VINCRISTINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; HUMAN; IMMUNOTHERAPY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME; WALDENSTROEM MACROGLOBULINEMIA;

AGED; CYCLOPHOSPHAMIDE; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; WALDENSTROM MACROGLOBULINEMIA;

EID: 0033037724     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1999.01461.x     Document Type: Article

References (19)

1. Barlogie, B., Jagannath, J., Desikan, K.R. Vesole, D., Siegel, D., Tricot, G., Munshi, N.C., Passas, A., Singhal, S., Mehta, J., Anaissie, E., Dhodaokar, M., Naucke, S., Cromer, J., Sawyer, J., Epstein, J., Spoon, D., Ayers, D., Cheson, B. & Crowley, J. (1999) Total therapy with tandem transplants for newly diagnosed multiple myeloma. Blood, 97, 55-65.
2. Barlogie, R., Jagannath, S., Vesole, D., Naucke, S., Cheson, B., Mattox, S., Bracy, D., Salmon, S., Jacobson, J., Crowley, & Tricot, G. (1997) Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma. Blood, 89, 789-793.
3. Bergsagel, D. (1995) The incidence and epidemiology of plasma cell neoplasms. Stem Cells, 13, 1-9.
4. Carella, A.M. (1990) Alpha-interferon therapy in advanced unresponsive immunoblastic lymphoma evolved from Waldenström's macroglobulinemia. (Letter). Haematologica, 75, 581.
5. Case, D.C., Jr (1982) Combination chemotherapy (M-2) protocol (BCNU, cyclophosphamide, vincristine, melphalan and prednisone) for Waldenström's macroglobulinemia, preliminary report. Blood, 59, 934-937.
6. Case, D.C., Jr. Ervin, T.J., Boyd, M.A. & Redfield, D.L. (1991) Waldenström's macroglobulinemia: long-term results with the M-2 protocol. Cancer Investigation, 9, 1-7.
7. De Rosa, G., De Renzo, A., Buffardi, S. & Rotoli, B. (1989) Treatment of Waldenström's macroglobulinemia with interferon. Haematologica, 74, 313-315.
8. Desikan, K.R., Jagannath, S., Vesole, D.H., Siegel, D., Fassas, A., Munshi, N.C., Tindle, S., Nelson, J., Bracy, D., Mattox, S., Barlogie, B. & Tricot, G. (1998) Comparable engraftment kinetics following peripheral blood stem cell infusion mobilized with G-CSF with or without cyclophosphamide in multiple myeloma. Journal of Clinical Oncology, 16, 1547-1553.
9. Dhodapkar, M. Jacobson, J., Gertz, M., Crowley, J., Shurafa, M., Salmon, S., Kyle, R. & Barlogie, B. (1997) Phase II intergroup trial of fludarabine in Waldenström's macroglobulinemia: results of Southwest Oncology Group trial (SWOG 9003) in 220 patients. Blood, 90, 577a.
10. Dimopoulos, M.A. & Alexanian, R. (1994) Waldenström's macroglobulinemia. Blood, 83, 1452-1459.
11. Dimopoulos, M.A., Kantarjian, H., Weber, D., O'Brian, S., Estey, E., Delasalle, K., Rose, E., Cabanillas, F., Keating, M. & Alexanian, R. (1994a) Primary therapy of Waldenström's macroglobulinemia with 2-chlorodeoxyadenosine. Journal of Clinical Oncology, 12, 2694-2698.
12. Dimopoulos, M.A., O'Brian, S., Kantarjian, H., Estey, E., Keating, M.J. & Alexanian, R. (1993) Treatment of Waldenström's macroglobulinemia with nucleoside analogues. Leukemia anti Lymphoma, 11, 105-108.
13. Dimopoulos, M.A., Weber, D., Delasalle, K.B., Keating, M. & Alexanian, R. (1995) Treatment of Waldenström's macroglobulinemia resistant to standard therapy with 2-chlorodeoxyadenosine: identification of prognostic factors. Annals of Oncology, 6, 49-52.
14. Dimopoulos, M.A., Weber, D.M., Kantarjian, H., Keating, M. & Alexanian, R. (1994b) 2-Chlorodeoxyadenosine therapy of patients with Waldenström macroglobulinemia previously treated with fludarabine. Annals of Oncology, 5, 288-289.
15. Fridrik, M.A., Jagar, G., Baldinger, C., Krieger, O., Chott, A. & Bettelheim, P. (1997) First-line treatment of Walderström's disease with cladribine. Annals of Hematology, 74, 7-10.
16. Groves, F.D., Travis, L.B., Devesa, S.S., Ries, L.A. & Praumeni, J.F. Jr (1998) Waldenström's macroglobulinemia: incidence patterns in the United States, 1998-1994. Cancer, 82, 1078-1081.
17. Onodera, S., Otaki, M., Oikawa, K., Mikami, M. & Sato, I. (1975) Treatment of multiple myeloma and macroglobulinemia Waldenström: a long-term follow-up study. Tohoku Journal of Experimental Medicine, 116, 317-325.
18. Siegel, D., Desikan, K.R., Mehta, J., Singhal, S., Fassas, A., Munshi, N.C., Anaissie, E., Naucke, S., Ayers, D., Spoon, D., Vesole, D., Tricot, G. & Barlogie, B. (1998) Age is not a prognostic variable with autotransplants for multiple myeloma. Blood, 93, 51-54.
19. Zinzani, P.L., Cherilinzoni, F., Bendandi, M., Zaccaria, A., Aitini, E., Salvucci, M. & Tura, S. (1995) Fludarabine treatment in resistant Waldenström's macroglobulinaemia. European Journal of Haematology, 54, 120-123.